Impact of patient and provider characteristics on the treatment and outcomes of colorectal cancer

Journal of the National Cancer Institute

Volumn 93, Issue 7, 2001, Pages 501-515

  Hodgson, David C ^a   Fuchs, Charles S ^b   Ayanian, John Z ^b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGE; AGED; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER SURVIVAL; CAUCASIAN; COLORECTAL CANCER; COLOSTOMY; COMORBIDITY; CONTROLLED STUDY; FEMALE; HEALTH CARE FACILITY; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; HEALTH SERVICE; HOSPITAL; HUMAN; MALE; MEDICAL DECISION MAKING; NEGRO; PERIOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; SOCIAL STATUS; SURGEON; SURGICAL MORTALITY; TREATMENT OUTCOME;

EID: 0035804647     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/93.7.501     Document Type: Review

References (85)

1. Outcomes research in oncology: History, conceptual framework, and trends in the literature
2. Variations in breast cancer treatment by patient and provider characteristics
3. Report on colon cancer
4. Surgeon-related factors and outcome in rectal cancer
5. Influence of volume of work on the outcome of treatment for patients with colorectal cancer
6. Hospital volume can serve as a surrogate for surgeon volume for achieving excellent outcomes in colorectal resection
7. The German experience: The surgeon as a prognostic factor in colon and rectal cancer surgery
8. Socioeconomic differences in cancer survival: A review of the evidence
9. Survival of American Indian and Hispanic cancer patients in New Mexico and Arizona, 1969-82
10. Users' guides to the medical literature. X. How to use an article reporting variations in the outcomes of health services
11. The consultant surgeons and pathologists of the Lothian and Borders Health Boards. Lothian and Borders large bowel cancer project: Immediate outcome after surgery
12. Physician and hospital factors associated with mortality of surgical patients
13. Population-based audit of colorectal cancer management in two UK health regions
14. Influence of hospital- and surgeon-related factors on outcome after treatment of rectal cancer with or without preoperative radiotherapy
15. Prognostic factors of rectum carcinoma-experience of the German Multicentre Study SGCRC
16. Influence of hospital and clinician workload on survival from colorectal cancer: Cohort study
17. Variations in treatment of rectal cancer: The influence of hospital type and caseload
18. Management and survival of patients with adenocarcinoma of the colon and rectum: A national survey of the Commission on Cancer
19. Treatment planning for adenocarcinoma of the rectum and sigmoid: A patterns of care study
20. Impact of hospital volume on operative mortality for major cancer surgery
21. Influence of hospital procedure volume on outcomes following surgery for colon cancer
22. Colorectal surgeons in district general hospitals produce similar survival outcomes to their teaching hospital colleagues: Review of 5-year survivals in Manchester
23. Management of colorectal cancer in Medicare health maintenance organizations
24. Perioperative management of colon cancer under Medicare risk programs
25. Survival and treatment for colorectal cancer Medicare patients in two group/staff health maintenance organizations and the fee-for-service setting
26. Care of patients with colorectal cancer. A comparison of a health maintenance organization and fee-for-service practices
27. Quality of care for colorectal cancer in a fee-for-service and health maintenance organization practice
28. Choice of cancer therapy varies with age of patient
29. Race, treatment, and survival among colorectal carcinoma patients in an equal-access medical system
30. The influence of patient age on the diagnosis and treatment of lung and colorectal cancer
31. The influence of age on resection rates and postoperative mortality in 6457 patients with colorectal cancer
32. Effects of health insurance and race on colorectal cancer treatments and outcome
33. Surgery for colorectal cancer: Race-related differences in rates and survival among Medicare beneficiaries
34. Substantial variation in therapy for colorectal cancer across Europe: EUROCARE analysis of cancer registry data for 1987
35. Colon cancer in the elderly: Evidence for major improvements in health care and survival
36. Determinants of survival in older cancer patients
37. Colon cancer treatment in rural North and South Carolina
38. A population-based study of rectal cancer: Permanent colostomy as an outcome
39. Age and sex are independent predictors of 5-fluorouracil toxicity. Analysis of a large scale phase III trial
40. Haematological and non-haematological toxicity after 5-fluorouracil and leucovorin in patients with advanced colorectal cancer is significantly associated with gender, increasing age and cycle number
41. Toxicity of fluorouracil in patients with advanced colorectal cancer: Effect of administration schedule and prognostic factors
42. Adjuvant chemotherapy for colon cancer (CC) is beneficial without significantly increased toxicity in elderly patients (pts): Results from a 3351 pt meta-analysis
43. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: Results from NSABP protocol R-01
44. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma
45. Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older
46. Patterns of care related to age of breast cancer patients
47. Outcome of surgery for colorectal cancer in a defined population in Sweden from 1984 to 1986
48. Factors influencing mortality after curative resection for large bowel cancer in elderly patients
49. A population-based study of the incidence, mortality and outcomes in patients following surgery for colorectal cancer in Western Australia
50. Operative mortality in carcinoma of the rectum. Results of the German multicentre study
51. Economic status and survivorship in digestive system cancers
52. Survival in patients with large-bowel cancer. A population-based investigation from the Melbourne colorectal cancer study
53. Racial and socioeconomic status differences in survival of colorectal cancer patients in Hawaii
54. Management and survival of adenocarcinoma of the rectum in the United States: Results of a national survey by the American College of Surgeons
55. Long-term cancer patient survival in the United States
56. Survival of colorectal cancer patients in Europe during the period 1978-1989
57. Comparisons of colon-cancer survival among European countries: The eurocare study
58. Large-bowel cancer in the young: A national survival study
59. Race, socioeconomic status, and other prognostic factors for survival from colo-rectal cancer
60. Association between age and local recurrence of rectal cancer: Results from a retrospective study of 902 patients
61. Outcomes among African-Americans and Caucasians in colon cancer adjuvant therapy trials: Findings from the National Surgical Adjuvant Breast and Bowel Project
62. Prediction of outcome after curative resection for large bowel cancer
63. Survival of colorectal cancer patients in relation to duration of symptoms and other prognostic factors
64. Women experience greater toxicity with 5-FU-based chemotherapy (CTX) for colorectal cancer (CC): A North Central Cancer Treatment Group (NCCTG) meta-analysis
65. Surgical adjuvant therapy of large-bowel carcinoma: An evaluation of levamisole and the combination of levamisole and fluorouracil
66. Influence of socioeconomic status on prognosis of colorectal cancer. A population-based study in Cote D'Or, France
67. Treatment differences between blacks and whites with colorectal cancer
68. Determinants of black/white differences in colon cancer survival
69. Do black elderly Medicare patients receive fewer services? An analysis of procedure use for selected patient conditions
70. Racial disparity in the incidence and case-fatality of colorectal cancer: Analysis of 329 United States counties
71. Trends in the survival of American Indian, Hispanic, and non-Hispanic white cancer patients in New Mexico and Arizona, 1969-1994
72. Cancer incidence and survival among American Indians registered for Indian health service care in Montana, 1982-1987
73. Cancer survival among American Indians in western Washington State (United States)
74. Associations between community income and cancer survival in Ontario, Canada, and the United States
75. An international comparison of cancer survival: Toronto, Ontario, and Detroit, Michigan, metropolitan areas
76. Quality of life in survivors of colorectal carcinoma
77. Pre-operative chemoradiotherapy and total mesorectal excision surgery of rectal cancer: Towards the eradication of pelvic failures?
78. Local recurrence after curative excision of the rectum for cancer without adjuvant therapy: Role of total anatomical dissection
79. Rural physicians' understanding of the state-of-the-art in breast, colon and rectum cancer treatment
80. Geographic variation in patient surveillance after colon cancer surgery
81. Current follow-up strategies after resection of colon cancer. Results of a survey of members of the American society of colon and rectal surgeons
82. Bowel surveillance patterns following ad diagnosis of colorectal cancer in medicare beneficiaries
83. Surveillance after curative colon cancer resection: Practice patterns of surgical subspecialists
84. Geographic and patient variation among Medicare beneficiaries in the use of follow-up testing after surgery for nonmetastatic colorectal carcinoma